Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin-loaded microsphere arterial embolization plus radical radiotherapy versus conventional chemoradiotherapy for locally advanced cervical cancer
ChiCTR2100054519Phase 2Recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cisplatin in Cervical Cancer (CC) (2 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoints: objective response rate and disease control rate. Started Jan 2022; status: recruiting.
02
Drugs
cisplatin
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on ChiCTR2100054519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054519.